Impact of syndemic heavy drinking, smoking, and depression on mortality among MSM with and without HIV: A longitudinal study
- PMID: 39662355
- PMCID: PMC11729611
- DOI: 10.1016/j.drugalcdep.2024.112523
Impact of syndemic heavy drinking, smoking, and depression on mortality among MSM with and without HIV: A longitudinal study
Abstract
Background: Heavy drinking, smoking, and depression are common among men who have sex with men (MSM). The association of co-occurring longitudinal patterns of these conditions and mortality among MSM were tested, applying a syndemic framework - the interaction of two or more conditions that contribute to poor health outcomes.
Methods: Longitudinal data from 1999 to 2018 from the Multicenter AIDS Cohort Study of 3046 MSM were analyzed. Group-based trajectories models (GBTM) of alcohol use, smoking, and depressive symptoms were developed. Syndemic phenotypes were defined based on overlapping high-risk group membership in the GBTM for each condition (i.e., heavy drinking, current smoking, severe depressive symptoms). Cox proportional hazards models estimated confounder-adjusted associations of syndemic phenotypes with mortality (National Death Index, n = 395; median follow-up 16.0 years). An interaction between HIV and syndemic phenotypes on mortality was tested.
Results: Syndemic phenotypes included no high-risk conditions (63 %), heavy drinking only (3 %), smoking only (16 %), depressive symptoms only (10 %), and two or more high-risk trajectories (9 %, sustained syndemic). Among MSM, the syndemic was associated with greater mortality risk compared to no conditions (hazard ratio [HR] 4.48, 95 % confidence interval [CI] 3.21, 6.26) or any single condition (heavy drinking HR 1.84, CI 0.90, 3.75; smoking HR 2.70, CI 2.03, 3.59; depression HR 2.31, CI 1.69, 3.14). The interaction between syndemic phenotype and HIV on mortality risk was significant.
Conclusions: The long-term clustering of high-risk drinking, smoking, and depressive symptoms occurred in nearly 10 % of MSM and was associated with increased mortality risk, especially among MSM living with HIV.
Keywords: Alcohol; Depression; HIV; MSM; Mortality; Smoking; Syndemic; Trajectory.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest Dr. Kizer reports stock ownership in Abbott, Bristol Myers Squibb, Johnson & Johnson, Medtronic, Merck, and Pfizer. Dr. Lahiri receives grant funding from Merck and serves on the Advisory Board for Theratechnologies, Inc. Dr Palella has been a consultant or on the Speakers’ Bureau for ViiV, Gilead, Janssen and Merck. None of the other authors had any financial or other conflicts of interest.
Figures
References
-
- Akhtar-Khaleel WZ, Cook RL, Shoptaw S, Surkan PJ, Teplin LA, Stall R, Beyth RJ, Manini T, Plankey M, 2016. Long-term cigarette smoking trajectories among HIV-seropositive and seronegative MSM in the multicenter AIDS cohort study. AIDS Behav. 20 (8), 1713–1721. 10.1007/s10461-016-1343-8. - DOI - PMC - PubMed
-
- Andruff H, Carraro N, Thompson A, Gaudreau P, Louvet B, 2009. Latent class growth modelling: a tutorial. Tutor. Quant. Methods Psychol. 5 (1), 11–24. 10.20982/tqmp.05.1.p011. - DOI
-
- Ash M, Mackereth C, 2013. Assessing the mental health and wellbeing of the lesbian, gay, bisexual and transgender population. Community Pract.: J. Community Pract. Health Visit. Assoc. 86 (3), 24–27. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 HL146245/HL/NHLBI NIH HHS/United States
- U01 HL146208/HL/NHLBI NIH HHS/United States
- KL2 TR001432/TR/NCATS NIH HHS/United States
- U01 HL146242/HL/NHLBI NIH HHS/United States
- TL1 TR001431/TR/NCATS NIH HHS/United States
- U01 HL146193/HL/NHLBI NIH HHS/United States
- U01 HL146194/HL/NHLBI NIH HHS/United States
- U01 HL146241/HL/NHLBI NIH HHS/United States
- P30 AI027767/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- U01 HL146333/HL/NHLBI NIH HHS/United States
- K01 AA029042/AA/NIAAA NIH HHS/United States
- U01 HL146205/HL/NHLBI NIH HHS/United States
- P30 MH116867/MH/NIMH NIH HHS/United States
- UL1 TR001409/TR/NCATS NIH HHS/United States
- K23 AI124913/AI/NIAID NIH HHS/United States
- T32 DA035167/DA/NIDA NIH HHS/United States
- U01 HL146192/HL/NHLBI NIH HHS/United States
- P30 AI073961/AI/NIAID NIH HHS/United States
- U01 HL146201/HL/NHLBI NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- F31 AA028751/AA/NIAAA NIH HHS/United States
- U01 HL146202/HL/NHLBI NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL146240/HL/NHLBI NIH HHS/United States
- U01 HL146203/HL/NHLBI NIH HHS/United States
- K01 HL137557/HL/NHLBI NIH HHS/United States
- UL1 TR003098/TR/NCATS NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
